New Medicines, Inspired By Protein Communities

Who We Are

Interline Therapeutics is a drug discovery company focused on systematically elucidating protein communities. We use our discovery platform to identify new medicines targeting genetically validated signaling pathways and to ensure that our drug candidates comprehensively correct dysfunctional disease networks.

Protein interaction dynamics inform cellular, structural, and evolutionary biological mechanisms. Broadly linking genomic variation to changes in protein interactions will impact drug discovery by revealing pathways that drive disease progression.

Wade Harper

Founding Scientific Advisor

Join Our Team

Interline is creating a culture centered around our dual commitments to patients and employees. We prioritize deep science, rapid innovation and mutual empowerment. We are growing a diverse and inclusive team with individuals united by our common values.


For press inquiries click here


Interline Therapeutics Launches With $92 Million to Map and Correct Dysfunctional Protein Communities

May 13, 2021

Fierce Biotech

Foresite, Arch fuel $92M round for Interline Therapeutics, a biotech taking aim at protein communities

May 13, 2021


Interline Therapeutics Inks $92M For Drug Discovery

May 13, 2021